menu
    • menu

    Company profile for Zucara Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type 1 diabetes is not properly controlled. It has demonstrated potential to specifically block somatostatin type 2 receptors in the pancreas thereby preventing hypoglycemia and restorin...
    Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type 1 diabetes is not properly controlled. It has demonstrated potential to specifically block somatostatin type 2 receptors in the pancreas thereby preventing hypoglycemia and restoring natural glucose levels in the blood.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Zucara TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1300-661 University Avenue, Toronto, ON M5G 0B7
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zucara.ca/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zucara Therapeutics Reports Positive Results from Phase 1b Trial of ZT-01
    Zucara Therapeutics Reports Positive Results from Phase 1b Trial of ZT-01

    22 Jun 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zucara-therapeutics-reports-positive-results-from-phase-1b-trial-of-zt-01-301572954.html

    PRNEWSWIRE
    22 Jun 2022
    Share Share
    Zucara Tx Publishes Preclinical Study Demonstrating ZT-01's in Type 1 Diabetes
    Zucara Tx Publishes Preclinical Study Demonstrating ZT-01's in Type 1 Diabetes

    08 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zucara-therapeutics-announces-publication-of-preclinical-study-demonstrating-zt-01s-ability-to-restore-glucagon-release-in-type-1-diabetes-301477414.html

    PRNEWSWIRE
    08 Feb 2022
    Share Share
    Zucara Therapeutics Doses First Patients in Phase 1b Trial of ZT-01
    Zucara Therapeutics Doses First Patients in Phase 1b Trial of ZT-01

    28 Jul 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zucara-therapeutics-doses-first-patients-in-phase-1b-trial-of-zt-01-301342713.html

    PRNEWSWIRE
    28 Jul 2021
    Share Share
    Zucara Therapeutics Successfully Completes Single and Multiple Ascending Dos
    Zucara Therapeutics Successfully Completes Single and Multiple Ascending Dos

    26 May 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zucara-therapeutics-successfully-completes-single-and-multiple-ascending-dose-phase-1-trial-of-zt-01-301299771.html

    PRNEWSWIRE
    26 May 2021
    Share Share
    Zucara Therapeutics Successfully Completes Single and Multiple Ascending Dose
    Zucara Therapeutics Successfully Completes Single and Multiple Ascending Dose

    26 May 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zucara-therapeutics-successfully-completes-single-and-multiple-ascending-dose-phase-1-trial-of-zt-01-301299771.html

    PRNEWSWIRE
    26 May 2021
    Share Share
    Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes
    Zucara Therapeutics Expands ZT-01 Development Program to Type 2 Diabetes

    02 Nov 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/11/02/2118345/0/en/Zucara-Therapeutics-Expands-ZT-01-Development-Program-to-Type-2-Diabetes.html

    GLOBENEWSWIRE
    02 Nov 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search